The Kraft Heinz Company

▲ Bull Case

• ◆Heinz international ($8–10B standalone value) is deeply embedded in KHC at a blended 9–10x EV/EBITDA. The brand delivers 13% organic growth in EM condiments, holds 32% ketchup market share in China, and operates in 200+ countries. Comparable international food brands trade at 18–22x EV/EBITDA on growth alone. If a Good Co/Bad Co split is revived, Heinz international could trade at $18–22B standalone — exceeding KHC's current market cap for a single asset — making it a call option embedded in every KHC share.
• ◆Cahillane's Brand Growth System has a documented track record at Kellanova, delivering consistent volume stabilization and gross margin expansion before the $36B Mars acquisition in 2024. If he can replicate even 50% of that success at KHC — starting with Heinz and Philadelphia as test cases — the narrative transitions from structural decline to active turnaround, re-rating the multiple from 10x to 13–14x on volumes that are merely less-bad.
• ◆$3B+ annual FCF provides flexibility that the GAAP P&L obscures: it covers the $1.9B dividend 1.5x+, reduces debt $500–700M/yr, and could fund highly accretive buybacks at sub-$22. The divergence between GAAP (terrible), adj. EPS (depressed trough), and FCF (robust) creates a perception gap that value investors can exploit — the business is generating real cash that the negative GAAP net income conceals.

▼ Bear Case

• ◆$15B+ in cumulative goodwill impairments since 2019 — including $9.3B in FY2025 alone — is management's own accounting verdict that acquired brand values are permanently impaired, not cyclically challenged. At 73% goodwill/intangibles in total assets, the remaining balance sheet is mostly unverifiable soft assets with continued impairment risk. Each impairment is an explicit acknowledgment that brands are worth far less than the original merger price implied.
• ◆North American secular decline is structural: GLP-1 drug users specifically reduce processed carbohydrate and processed meat intake; Gen Z's anti-ultra-processed-food movement targets exactly KHC's core brands; and private label cold cuts and cheese are competitively priced with improving quality. The $600M reinvestment can slow the decline but cannot reverse a 15-year secular shift. Even in the bull case, NA organic volumes plateau at -1 to 0% — they do not recover to +2–3%.
• ◆Berkshire Hathaway's 27.5% stake (325M shares registered for sale) represents a motivated seller: Buffett wrote down $3.8B in August 2025 and publicly called the investment a mistake — highly unusual for the world's most famous value investor. A Berkshire block trade at $24–26 would depress the stock for weeks, remove the floor buyer, and trigger institutional redemptions as the KHC Berkshire premium evaporates, making any near-term re-rating difficult.

“The primary debate: Is the $600M marketing reinvestment a genuine business restoration that will inflect NA organic volumes to positive territory by FY2028, or is it throwing good money at structurally impaired brands while the Berkshire exit and GLP-1 overhang suppress the multiple permanently? The bull says Cahillane has a documented playbook and Heinz international is underappreciated — even modest improvement in the top 5 brands changes the narrative. The bear says $15B+ in impairments is the market's and management's own verdict on brand quality; GLP-1 and private label are structural, not cyclical; and Berkshire is exiting for a reason. Resolution signals: Q2–Q3 2026 NA organic volume vs. guidance (-1.5% to -3.5%); any Berkshire Form 144 large block trade; Good Co/Bad Co split resumption announcement.”

• ◆Q2 2026 earnings (~Aug 2026): NA organic volume above guidance midpoint (-2.5%); Philadelphia/Heinz NA market share gains signal reinvestment ROI
• ◆Q3 2026 earnings (~Nov 2026): Nielsen/Circana scanner data showing brand share recovery in BGS pilot brands
• ◆FY2026 full year (Feb 2027): adj. EPS guidance for FY2027 at or above $2.25; improving volume trajectory
• ◆Good Co/Bad Co split announcement: Cahillane restarts Heinz international separation process after turnaround evidence accumulates
• ◆Berkshire inactivity: no large block sale filed, confirming overhang resolution and supporting re-rating
• ◆Heinz international sustaining 10%+ organic growth with distribution expansion to 40K+ points in EM markets
• ◆Q2–Q3 2026 NA organic volume exceeds guidance midpoint by 150bps (TKS-5 ADD trigger)

• ◆Berkshire large block sale below $24/share (30–40% probability, HIGH): distressed supply overhang, stock price crash, removal of floor buyer — monitor Form 144/4 filings
• ◆NA organic volume -5%+ for two consecutive quarters (25–30% probability, HIGH): confirms structural decline thesis; EPS falls to $1.50–1.80 with 8–9x multiple → $12–16 stock
• ◆Dividend cut or explicit payout reduction (10–15% probability, SEVERE): triggers income investor exodus and loss of yield support floor — monitor quarterly FCF and leverage commentary
• ◆Additional GAAP impairment >$5B in FY2026–FY2027 (20–25% probability, MEDIUM): signals continued brand value deterioration; cumulative $23B+ confirms merger as catastrophic value destruction
• ◆Credit downgrade to below investment grade (5–8% probability, SEVERE): would trigger refinancing crisis at 5%+ rates — monitor leverage vs. 4.5x EBITDA threshold
• ◆GLP-1 adoption exceeding 10% of US adults by 2028 (15–20% probability, HIGH): structural category impairment for processed carbohydrate and processed meat brands